POSLUMA-PSMA PET
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for POSLUMA-PSMA PET, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) [Phase 2]